Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,137 | -82,508 | -68,079 | -48,978 | -23,121 |
| Depreciation Amortization | 880 | 4,032 | 3,135 | 2,242 | 1,201 |
| Accounts payable and accrued liabilities | 1,021 | -4,927 | -2,488 | -770 | -3,539 |
| Other Working Capital | 681 | -9,286 | -9,182 | -5,180 | -5,008 |
| Other Operating Activity | 565 | 14,596 | 14,414 | 9,876 | 6,057 |
| Operating Cash Flow | $-6,990 | $-78,093 | $-62,200 | $-42,810 | $-24,410 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,872 | 13,170 | 20,075 | 15,054 | 9,525 |
| Investing Cash Flow | $13,872 | $13,170 | $20,075 | $15,054 | $9,525 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 27,860 | 27,860 | 27,899 | N/A |
| Other Financing Activity | -622 | -168 | 765 | 1,697 | -789 |
| Financing Cash Flow | $-622 | $27,692 | $28,625 | $29,596 | $-789 |
| Beginning Cash Position | 16,657 | 53,888 | 53,888 | 53,888 | 53,888 |
| End Cash Position | 22,917 | 16,657 | 40,388 | 55,728 | 38,214 |
| Net Cash Flow | $6,260 | $-37,231 | $-13,500 | $1,840 | $-15,674 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,990 | -78,093 | -62,200 | -42,810 | -24,410 |
| Free Cash Flow | -6,990 | -78,093 | -62,200 | -42,810 | -24,410 |